LYFE Capital — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that measures cell viability, morphology, electrophysiology, and metabolism at single-cell resolution across any cell type or 3D organoid system.
BiotechDeep TechSemiconductorsBoston, US
Jeffrey Abbott(Co-Founder & CEO)Vince Wu(Co-Founder & CTO)Duane Sword(Co-Founder & CBO)inDonhee Ham(Scientific Co-Founder)Hongkun Park(Scientific Co-Founder)Vince (Wenxuan) Wu(Founder)in
Co-investorsAnzu PartnersBantam GroupDraper AssociatesBoxOne Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.